Ionis Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
05.10.23
/
50%
€43.75
Target price
05.10.24
€61.66
Performance (%)
-3.47%
Price
03.07.24
€42.23
Summary
This prediction is currently active. With a performance of -3.47%, the BUY prediction for Ionis Pharmaceuticals Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 05.10.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ionis Pharmaceuticals Inc. | -5.483% | -5.483% |
iShares Core DAX® | 1.175% | -0.931% |
iShares Nasdaq 100 | 1.232% | 9.715% |
iShares Nikkei 225® | 1.563% | 3.040% |
iShares S&P 500 | 0.034% | 5.962% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Ionis Pharmaceuticals Inc. diskutieren
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $65.00 price target on the stock.
Ratings data for IONS provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Ionis Pharmaceuticals Inc.
Ionis Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€47.43
26.01.24
26.01.24
€64.40
26.01.25
26.01.25
-10.96%
03.07.24
03.07.24